Skip to Content

American BriVision Holding Corp ABVC

Rating as of

Morningstar’s Analysis

Valuation
Currency in USD
Is it the right time to buy or sell?
Find out with Morningstar Premium
Is it the right time to buy or sell?
Find out with Morningstar Premium

1-Star Price

PREMIUM

5-Star Price

PREMIUM

Economic Moat

PREMIUM

About Quantitative Ratings

Morningstar Quantitative ratings for equities (denoted on this page by) are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies withratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating. Click here for more on how to use these ratings.

Company Profile

Business Description

American BriVision Holding Corp is a clinical-stage biopharmaceutical company. Its focus is on enhancing the already available pharmaceutical products for cancer and other diseases and commercialize the same. Its products are ABV- 1501- ABVC, ABV- 1502- ABVC, and other. The company is into the research and development of compounds licensed by a Taiwanese company named BioLite Inc.

Contact
44370 Old Warm Springs Boulevard
Fremont, CA, 94538
T +1 845 291-1291
Sector Healthcare
Industry Biotechnology
Most Recent Earnings Sep 30, 2020
Fiscal Year End Dec 31, 2020
Stock Type Slow Growth
Employees 35